feed,title,long_url,short_url
GN:S:RL,Engaging patients for the duration: 3 ways to improve retention in oncology studies - BioPharma Dive,https://www.biopharmadive.com/spons/engaging-patients-for-the-duration-3-ways-to-improve-retention-in-oncology/618969/,https://bit.ly/3IvQuPk
GN:S:RL,Insilico Announces Successful Completion of Phase 0 Microdose Trial and Initiates Phase I Clinical Trial for its First AI-discovered Anti-fibrotic Product Candidate with Novel Target - Canada NewsWire,https://www.newswire.ca/news-releases/insilico-announces-successful-completion-of-phase-0-microdose-trial-and-initiates-phase-i-clinical-trial-for-its-first-ai-discovered-anti-fibrotic-product-candidate-with-novel-target-851327304.html,https://bit.ly/3K1DiBV
